Amgen Ventures

Amgen Ventures is the corporate venture capital arm of Amgen Inc., focusing on investments in early-stage biotechnology companies that align with Amgen's mission to serve patients with serious illnesses. The firm seeks to advance human therapeutics by supporting innovative companies in the biotechnology and life sciences sectors.

Operating globally, Amgen Ventures has a presence in North America, Europe, and the United Kingdom, with offices in San Diego, Seattle, San Francisco, Thousand Oaks, and Boston. The firm typically invests between $2 million and $10 million per transaction, aiming for an ownership stake of less than 15% in its portfolio companies.

The investment strategy of Amgen Ventures emphasizes sectors such as digital health and therapeutics, targeting companies that are developing novel treatments and technologies. By leveraging Amgen's extensive resources and expertise, the firm aims to foster innovation and accelerate the development of new therapies for patients worldwide.